These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 208167)

  • 21. Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
    Lehtonen A; Allonen H; Kleimola T
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):71-5. PubMed ID: 422304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A multicenter clinical comparison study between Tevacor and Trasicor in hypertension].
    Shmueli H; Rosenfeld J
    Harefuah; 1986 Jun; 110(11):550-2. PubMed ID: 3533738
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of the acetylator phenotype for the clinical use of dihydralazine.
    Siegmund W; Franke G; Biebler KE; Donner I; Kallwellis R; Kairies M; Scherber A; Hüller H
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S74-8. PubMed ID: 3842694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical experience with intravenous depressan ampules].
    Hennig D
    Z Urol Nephrol; 1975 Mar; 68(3):169-72. PubMed ID: 1227186
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of the therapeutic effect of dopegit and depressin in hypertension according to polycardiographic data].
    Berezhnitskiĭ MN; Mikhal'chuk BD
    Vrach Delo; 1976 Nov; (11):41-3. PubMed ID: 1014551
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.
    Motolese M; Muiesan G; Colombi A
    Eur J Clin Pharmacol; 1975; 8(1):21-31. PubMed ID: 786673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experience in the ambulatory treatment of primary arterial hypertension with a fixed oxprenolol-chlorthalidone combination].
    Zampaglione G; Ferrari O; Bianchi C; Bonifazi C; Coppetti S; Costanza G; Lanzarini L; Ricevuti A; Rinaldo R; Rizzi GM; Tavecchi L; Ziletti G; Distante S
    G Clin Med; 1980 Oct; 61(10):776-88. PubMed ID: 7239053
    [No Abstract]   [Full Text] [Related]  

  • 28. The use of dihydralazine infusion in the management of severe hypertension in pregnancy.
    Moodley J; Vasant RV
    Cent Afr J Med; 1986 Jun; 32(6):145-7. PubMed ID: 3568122
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of severe chronic cardiac insufficiency with dihydralazine. Short-and median-term results].
    Morand P; Lavigne G; Masson D; Latour F; Alison D
    Arch Mal Coeur Vaiss; 1979 Mar; 72(3):268-75. PubMed ID: 114137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison between metroprolol, alprenolol and oxprenolol in the treatment of hypertension.
    Tuomilehto J
    Acta Med Scand Suppl; 1979; 625():74-80. PubMed ID: 373397
    [No Abstract]   [Full Text] [Related]  

  • 31. The treatment of hypertension in older patients: a comparative study between a diuretic, a beta-receptor antagonist and their fixed combination.
    Forrest WA
    Practitioner; 1982 Apr; 226(1366):777-8. PubMed ID: 7045851
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative study of oxdralazine and dihydralazine in essential hypertension.
    Salvadeo A; Villa G; Segagni S; Piazza W; Criscuolo D
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):372-6. PubMed ID: 7030978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multicenter study with a fixed combination of oxprenolol/chlorthalidone in essential arterial hypertension].
    Albanesi Filho FM; Benchimol AB
    Arq Bras Cardiol; 1980 May; 34(5):409-14. PubMed ID: 7006573
    [No Abstract]   [Full Text] [Related]  

  • 34. Dihydralazine therapy and acetylator phenotype.
    Iisalo E; Laine T; Lehtonen A; Sellman R
    Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):119-24. PubMed ID: 429082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Simultaneous administration of dihydralazine, propranolol and a diuretic in the treatment of severe hypertension].
    Chodakowska J; Cybulska I; Raczyński J
    Pol Arch Med Wewn; 1977 Dec; 58(6):541-6. PubMed ID: 600831
    [No Abstract]   [Full Text] [Related]  

  • 36. A double-blind randomized evaluation of converting enzyme inhibition as the first-step treatment of mild to moderate hypertension.
    Sassano P; Chatellier G; Amiot AM; Alhenc-Gelas F; Corvol P; Ménard J
    J Hypertens Suppl; 1984 Dec; 2(2):S75-80. PubMed ID: 6100880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine].
    Gyntelberg F; Jacobsen K; Martlev A; Backer P
    Ugeskr Laeger; 1977 Mar; 139(11):641-6. PubMed ID: 320734
    [No Abstract]   [Full Text] [Related]  

  • 38. Oxprenolol and a thiazide diuretic together in the treatment of essential hypertension--a large general practice study.
    Forrest WA
    Br J Clin Pract; 1973 Sep; 27(9):331-5. PubMed ID: 4595072
    [No Abstract]   [Full Text] [Related]  

  • 39. [Long-term experiences with an antihypertensive combination].
    Hilgert A; Horch G
    Med Welt; 1982 Jul; 33(29-30):1067-70. PubMed ID: 6750310
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hydralazine in arterial hypertension. Randomized, double-blind comparison between conventional and slow-release preparations].
    Wulff K; Lenz K; Krogsgaard AR; Holst B
    Ugeskr Laeger; 1980 Jul; 142(29):1862-5. PubMed ID: 6996259
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.